Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov 29;6(2):FSO439.
doi: 10.2144/fsoa-2019-0028.

On the need for the development of a cancer early detection, diagnostic, prognosis, and treatment response system

Affiliations
Review

On the need for the development of a cancer early detection, diagnostic, prognosis, and treatment response system

Tobore Onojighofia Tobore. Future Sci OA. .

Abstract

Cancer is the second leading cause of noncommunicable disease deaths in the world. In 2018, there were over 18 million new cancer cases and approximately 10 million people died from the disease globally. In 2019, almost two million new cases of cancer will be diagnosed in USA and over 600,000 people are expected to die from the disease. The incidence of cancer is expected to rise because of lifestyle changes and a rapidly aging population. Evidence suggests that early detection is critical to reducing cancer morbidity and mortality. In this paper, the development of an integrated smart wearable and biomarker detection system is proposed to help reduce cancer morbidity and mortality. The potential benefits and limitations of the system are discussed.

Keywords: ISWEBDS; bioelectronics; bioengineering; biomarkers; biosensors; biotechnology; cancer early detection; diagnostic biomarkers; nanotechnology; personalized/precision medicine; predictive biomarkers; prognostic biomarkers; targeted therapy; wearables.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.

Figures

Figure 1.
Figure 1.. Integrated smart wearable and biomarker detection system.
(A) Biosensors implanted in the body. (B) Smart wearable receiving signals from biosensors.

References

    1. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388(10053), 1459–1544 (2016). - PMC - PubMed
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J. Clin. 69(1), 7–34 (2019). - PubMed
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68(6), 394–424 (2018). - PubMed
    1. Weir HK, Thompson TD, Soman A, Møller B, Leadbetter S. The past, present, and future of cancer incidence in the United States: 1975 through 2020. Cancer 121(11), 1827–1837 (2015). - PMC - PubMed
    1. You W, Henneberg M. Cancer incidence increasing globally: the role of relaxed natural selection. Evol. Appl. 11(2), 140–152 (2017). - PMC - PubMed

LinkOut - more resources